Skip to main content
. Author manuscript; available in PMC: 2023 Jul 17.
Published in final edited form as: Vaccine. 2021 Feb 12;39(10):1485–1492. doi: 10.1016/j.vaccine.2021.02.004

Table 3.

Prevalence of hepatitis B virus infection markers among children born in 2006–2015 by age group and sex across survey sites — Ukraine, 2017

 Variable Total No. tested Anti-HBc-positive HBsAg-positive
No. positive Weighted
%
95% CI P value No. positive Weighted
%
95% CI P value
Zakarpattya
Overall 1,268 56 5.2 3.1–8.7 6 0.7 0.3–1.4
Age groups
 2006 –2009 cohorts 667 21 3.3 2.1–5.2 0.092 1 0.1 0.0 –0.8 0.045
 2010 –2015 cohorts 601 35 6.4 3.4–1.5 5 1.0 0.4–2.2
Sex
 Male 675 26 4.5 2.6–7.8 0.280 2 0.5 0.1–1.7 0.450
 Female 593 30 5.9 3.3–10.4 4 0.9 0.3–2.2
Sumy
Overall 1,380 12 0.8 0.4–1.6 1 0.1 0.0–0.4
Age groups
 2006 –2009 cohorts 699 8 1.1 0.4–2.7 0.423 1 0.1 0.0–0.8 n/a
 2010 –2015 cohorts 681 4 0.6 0.2–1.8 0 0.0 0.0–0.6*
Sex
 Male 719 5 0.6 0.2–1.6 0.332 0 0.0 0.0–0.5* n/a
 Female 661 7 0.9 0.4–2.0 1 0.1 0.0–0.8
Odessa
Overall 1,265 14 1.0 0.4–2.2 0 0.0 0.0–0.3*
Age groups
 2006 –2009 cohorts 663 11 1.6 0.8–3.1 0.033 0 0.0 n/a
 2010 –2015 cohorts 602 3 0.5 0.1–2.2 0 0.0
Sex
 Male 654 6 0.9 0.3–2.6 0.669 0 0.0 n/a
 Female 611 8 1.1 0.5–2.3 0 0.0
Kyiv City
Overall 683 7 1.1 0.5–2.3 2 0.1 0.0–0.8
Age groups
 2006 –2009 cohorts 352 3 0.8 0.3–2.5 0.640 1 0.3 0.1–1.6 n/a
 2010 –2015 cohorts 331 4 1.2 0.5–3.1 0 0.0 0.0–1.2*
Sex
 Male 343 3 1.0 0.3–2.9 0.800 0 0.0 0.0–1.1* n/a
 Female 340 4 1.2 0.4–3.1 1 0.2 0.0–1.5

Note: CI, confidence interval; n/a, not applicable (could not be calculated because of zero prevalence); anti-HBc, antibodies against core antigen of hepatitis B virus; HBsAg, surface antigen of hepatitis B virus.

*

Crude estimate of CI (due to zero value of prevalence)